EcoR1 Capital, LLC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 81 filers reported holding DESIGN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.7%.

Quarter-by-quarter ownership
EcoR1 Capital, LLC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$9,079,105
-79.0%
884,903
-65.7%
0.28%
-78.3%
Q3 2022$43,182,000
+17.1%
2,582,668
-2.0%
1.27%
+0.1%
Q2 2022$36,878,000
-3.7%
2,634,178
+11.1%
1.27%
+6.3%
Q1 2022$38,299,000
-16.9%
2,371,445
+10.1%
1.20%
-18.4%
Q4 2021$46,096,000
+68.4%
2,152,997
+15.6%
1.47%
+54.3%
Q3 2021$27,369,000
+9.2%
1,863,098
+47.9%
0.95%
+1.6%
Q2 2021$25,062,000
-26.3%
1,260,019
+10.7%
0.94%
-37.9%
Q1 2021$34,024,0001,137,9401.51%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders